Press release
Cancer Tumor Profiling Market Global Research Report On Latest Trend, Segmentation And Opportunities Forecast To 2026
Cancer Tumor Profiling Market
Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-sample/2717
The advent of tumor/cancer profiling has assisted in overcoming the limitation of traditional cancer diagnostic methods as well as setting up a gold standard for tumor classification. The targeted approach especially using NGS technology delivers high sensitivity to detect tumor subclone and rare mutations by detecting the mutation-causing agent in cancer. This has ultimately fueled the adoption of cancer profiling methods among oncologists. In addition, rapid rise in burden of cancer and increase in funding from government for devising cancer diagnosing methods augment the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled oncologists & related professionals restrain the market growth. Moreover, untapped markets, such as China and India, offer lucrative opportunities for the market growth due to rise in demand for better diagnosis and treatment of various types of cancer.
The key players operating in the global cancer/tumor profiling market have adopted product launch as their key developmental strategy and have focused on launching innovative products to cater to consumer requirements and strengthen their market shares. The major companies profiled in the report include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe, BD Biosciences, and Siemens Healthineers.
The fluorescence in situ hybridization (FISH) segment generated the highest revenue in 2016, and is anticipated to dominate the market throughout the forecast period. This attributed to increase in demand for FISH in cancer profiling, as this technology helps in identifying the predictive or prognostically important genetic variants in cancer, and is successfully used for the prediction prognosis of breast cancer.
The metabolomics segment is expected to witness the highest growth rate in the global market registering a CAGR of 20.2% from 2017 to 2023, owing to the recent advances in metabolomics technologies that have deeper insights about the metabolism of cancer. Moreover, determining the abundance of all the metabolites in a cancer cells is possible through metabolomics profiling techniques.
The personalized medicine segment accounted for one-fourth share of the global market in 2016, and is expected to register the highest CAGR of 19.1% throughout the forecast period. This is attributed to increased focus of oncologists towards personalized cancer care, thereby ensuring better treatment methods with fewer side effects. Furthermore, personalized medicines offer better understanding of genetic differences in patients to govern the susceptibility to a particular cancer or response to a specific treatment. This aids in providing targeted therapy, thereby decreasing the overall cost of treatment with minimal side effects to patients.
Key Findings of the Cancer/tumor Profiling Market:
o The genomics segment dominated the global cancer/tumor profiling market accounting for two-fifths share of the global market in 2016.
o The biomarker discovery segment is the largest application of global market in 2016, and is expected to grow at a CAGR of 17.4% during the forecast period.
o U.S. dominated the North America cancer/tumor profiling market, accounting for the maximum share of the global market in 2016.
o Asia-Pacific is exhibited to grow at a significant CAGR of 19.3% during the forecast period.
o India was the fastest growing country in the Asia-Pacific cancer/tumor profiling market in 2016, registering a CAGR of 20.8%, and is anticipated to continue this trend during the forecast period.
o The in-situ hybridization segment is expected to grow at the highest rate, registering a CAGR of 19.8% from 2017to 2023.
Asia-Pacific witnessed the highest growth rate in the global market from 2017-2023. This is attributed to rise in awareness related to cancer profiling technologies and increase in investments by the regional market players in the diagnostic laboratories for cancer diagnosis. For instance, in 2011, Metropolis India launched fluorescent in-situ hybridization (FISH) technology to detect genetic abnormalities and diagnose cancer. These factors are expected to boost the market growth in the near future
Inquiry for Buying Report@ https://www.alliedmarketresearch.com/purchase-enquiry/2717
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Tumor Profiling Market Global Research Report On Latest Trend, Segmentation And Opportunities Forecast To 2026 here
News-ID: 1946576 • Views: β¦
More Releases from Allied Market Research
Aluminum Alloy Wheel Market Projected to Accelerate to $31.9 Billion by 2032, Fu β¦
According to a new report published by Allied Market Research, titled, "Aluminum Alloy Wheel Market," The aluminum alloy wheel market was valued at $16.4 billion in 2022, and is estimated to reach $31.9 billion by 2032, growing at a CAGR of 7.2% from 2023 to 2032.
π° ππ¨π°π§π₯π¨ππ πππ¦π©π₯π πππ ππ¬ - https://www.alliedmarketresearch.com/request-sample/A10064
Aluminum alloy wheels are special type of light weight alloy wheels which are designed to reduce the overall weight ofβ¦
Automotive Carbon Fiber Market Poised to Reach $64.1 Billion by 2032, Driving In β¦
The global automotive carbon fiber market size was valued at $24.13 billion in 2022, and is projected to reach $ 64.05 billion by 2032, growing at a CAGR of 11.16% from 2023 to 2032.
π° ππ¨π°π§π₯π¨ππ πππ¦π©π₯π πππ ππ¬ - https://www.alliedmarketresearch.com/request-sample/A12796
Allied Market Research published a report, titled, "Automotive Carbon Fiber Market by Vehicle Type (Passenger Vehicle, Commercial Vehicle, and Two-Wheelers), Material (Polyacrylonitrile (PAN), Pitch), Sales Channel (OEM, Aftermarket), and Application (Structural Assembly,β¦
Intermodal Freight Transportation Market Size, Shares, Opportunities, Industry T β¦
According to a new report published by Allied Market Research, titled, "Intermodal Freight Transportation Market," The Intermodal Freight Transportation Market Size was valued at $42.5 billion in 2022, and is estimated to reach $109.5 billion by 2032, growing at a CAGR of 10.4% from 2023 to 2032.
ππ¨π°π§π₯π¨ππ πππ¦π©π₯π πππ ππ¬ - https://www.alliedmarketresearch.com/request-sample/A49990
πππππ’π§π πππ«π€ππ ππ₯ππ²ππ«π¬:
UPFIELD B.V.
KITE HILL
MIYOKO'S CREAMERY
TOFUTTI BRANDS, INC.
TREELINE TREENUT CHEESE COMPANY, LLC.
VTOPIAN ARTISAN CHEESES, LLC
SAPUTO INC.
PARMELA CREAMERY
GOOD PLANET FOODS INC.
NUTSβ¦
Pharmaceutical Warehousing Market on Track to Hit $39.00 Billion Globally by 203 β¦
According to a new report published by Allied Market Research, titled, "Pharmaceutical Warehousing Market," The market size of pharmaceutical warehousing industry was valued at $24.8 billion in 2022, and is estimated to garner $39.0 billion by 2032, growing at a CAGR of 4.7% from 2023 to 2032.
π° ππ¨π°π§π₯π¨ππ πππ¦π©π₯π πππ ππ¬ - https://www.alliedmarketresearch.com/request-sample/A124142
Pharmaceutical warehousing is the storage and management of pharmaceutical items under regulated conditions, such as in cold chain andβ¦
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by β¦
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingβ¦
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio β¦
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostβ¦
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p β¦
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strengthβ¦
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve β¦
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:β¦
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance β¦
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchβ¦
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C β¦
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on topβ¦
